Records containing: Pheochromocytoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-24
Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma
CLINICAL_TRIALS study record update · 2026-04-24
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
CLINICAL_TRIALS study record update · 2026-04-23
A Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
CLINICAL_TRIALS study record update · 2026-04-14
Single-arm Open-label Phase I/II Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
CLINICAL_TRIALS study record update · 2026-04-07
Validation and Extension Study of the Predictive Model for Intraoperative Hemodynamic Instability in Pheochromocytoma/Paraganglioma Resection - a Single-center, Prospective, Observational Cohort Study
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2026-04-02
Open Access Protocol of Targeted Radiotherapy With I-metaiodobenzylguanidine (I-MIBG) in Patients With Resistant Neuroblastoma or Malignant Chromaffin Cell Tumors
CLINICAL_TRIALS study record update · 2026-03-17
Phase I Dose Escalation Study of Systemically Administered IL13Ra2 Chimeric Antigen Receptor (CAR) T Cells After a Nonmyeloablative Conditioning Regimen in Patients With Metastatic Melanoma and Other Solid Tumors
CLINICAL_TRIALS study record update · 2026-03-10
Phase I/II Trial of Systemic Targeted Radioligand Therapy (TRT) With Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR Positive (SSTR+) Gastrointestinal (GI) Neuroendocrine Tumors (NET) and Pheochromocytoma/Paragangliomas Previously Treated With Systemic Radioligand Therapy
CLINICAL_TRIALS study record update · 2026-03-02
Exploratory Phase II Study of LAnreotide in Metastatic Pheochromocytoma/PARAganglioma (LAMPARA)
CLINICAL_TRIALS study record update · 2026-03-02
Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma
CLINICAL_TRIALS study record update · 2026-02-27
Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Patients With Pheochromocytoma and Paraganglioma
CLINICAL_TRIALS study record update · 2026-02-06
Clinical Application of New Pheochromocytoma Markers: INSERM Pilot Study of the Specificity of Elevated Plasma EM66 Concentrations in Patients With Pheochromocytoma or Paraganglioma Compared to Patients With Essential Hypertension
CLINICAL_TRIALS study record update · 2026-01-30
A Phase 1/2 Trial of a Novel Therapeutic Vaccine (EO2401) in Combination With Immune Check Point Blockade, for Treatment of Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma
CLINICAL_TRIALS study record update · 2026-01-14
Institutional Registries of Rare Diseases at Hospital Italiano de Buenos Aires (HIBA)
CLINICAL_TRIALS study record update · 2025-12-03
18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma
CLINICAL_TRIALS study record update · 2025-10-15
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
CLINICAL_TRIALS study record update · 2025-10-01
Cardiovascular Complications After Adrenalectomy for Pheochromocytoma and Non-secreting Tumors - A Prospective Observational Multicenter European Study (HEMODYNAMICS)
CLINICAL_TRIALS study record update · 2025-09-26
the Clinical Application of Somatostatin Receptor and Norepinephrine Transporter Targeted Imaging for the Diagnosis and Staging of Neuroblastoma and Pheochromocytoma/Paraganglioma
CLINICAL_TRIALS study record update · 2025-08-26
Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen
CLINICAL_TRIALS study record update · 2025-08-07
A Prospective Exploratory Study Evaluating the Diagnostic Usefulness of 18F-mFBG PET Imaging in Pheochromocytoma
CLINICAL_TRIALS study record update · 2025-07-20
Using Behavioral Economics and Implementation Science to Advance the Use of Genomic Medicine Utilizing an EHR Infrastructure Across a Diverse Health System
CLINICAL_TRIALS study record update · 2025-06-19
Exploratory Basket Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. CABATEN Study
CLINICAL_TRIALS study record update · 2025-06-13
Evaluation of the Safety and Sensitivity of 68Ga-DOTATOC PET/CT for Imaging NET Patients
CLINICAL_TRIALS study record update · 2025-06-12
A Pilot Study for Randomized Controlled Trial on the Effect and Safety of Omitting Preoperative Alpha-adrenergic Blockade for Normotensive Pheochromocytoma
CLINICAL_TRIALS study record update · 2025-04-29
A Single-arm, Multicenter, Prospective Phase II Clinical Study of Anlotinib Combined With Benmelstobart in the First-line Treatment of Advanced Pheochromocytoma/Paraganglioma